Beihai Gofar Chuanshan Biological Co., Ltd. (SHA:600538)
China · Delayed Price · Currency is CNY 5.19
+0.02 (0.39%)
Sep 7, 2026, 2:55 PM CST
SHA:600538 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2,710 | 3,208 | 2,705 | 2,432 | 2,369 | 3,166 | |
Market Cap Growth | -15.80% | 18.61% | 11.21% | 2.66% | -25.17% | 4.86% |
Enterprise Value | 2,657 | 3,139 | 2,600 | 2,295 | 2,234 | 3,035 |
Last Close Price | 5.17 | 6.12 | 5.16 | 4.64 | 4.52 | 6.04 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | - | 68.00 | 301.93 |
PS Ratio | 8.11 | 9.77 | 7.95 | 6.59 | 5.15 | 7.46 |
PB Ratio | 3.92 | 4.58 | 3.44 | 2.77 | 2.47 | 3.43 |
P/TBV Ratio | 4.72 | 5.48 | 4.44 | 3.78 | 3.54 | 5.01 |
P/OCF Ratio | - | - | 1388.30 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 7.95 | 9.56 | 7.64 | 6.22 | 4.86 | 7.15 |
EV/EBITDA Ratio | - | - | - | - | 59.50 | 135.25 |
EV/EBIT Ratio | - | - | - | - | 91.09 | 322.22 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.10 | 0.08 | 0.05 | 0.02 | 0.02 | 0.01 |
Debt / EBITDA Ratio | - | - | 15.72 | - | 0.36 | 0.26 |
Net Debt / Equity Ratio | -0.10 | -0.13 | -0.13 | -0.16 | -0.16 | -0.20 |
Net Debt / EBITDA Ratio | 7.76 | 5.99 | 64.94 | 18.66 | -4.16 | -8.20 |
Net Debt / FCF Ratio | 2.32 | 4.78 | 12.71 | 4.98 | 6.65 | 6.21 |
Asset Turnover | 0.37 | 0.35 | 0.34 | 0.34 | 0.41 | 0.40 |
Inventory Turnover | 3.02 | 3.03 | 3.13 | 3.39 | 4.21 | 4.84 |
Quick Ratio | 3.36 | 2.85 | 2.83 | 2.55 | 2.50 | 2.61 |
Current Ratio | 4.15 | 3.53 | 3.46 | 3.08 | 3.05 | 3.23 |
Return on Equity (ROE) | -12.48% | -11.64% | -11.03% | -8.82% | 3.89% | 1.12% |
Return on Assets (ROA) | -1.47% | -1.97% | -0.94% | -1.21% | 1.38% | 0.55% |
Return on Invested Capital (ROIC) | -3.45% | -4.55% | -2.14% | -2.77% | 2.77% | 0.87% |
Return on Capital Employed (ROCE) | -2.80% | -3.90% | -1.80% | -2.40% | 2.50% | 1.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.44% | -2.73% | -3.47% | -3.38% | 1.47% | 0.33% |
FCF Yield | -1.07% | -0.62% | -0.30% | -1.15% | -0.99% | -0.94% |
Payout Ratio | - | - | - | - | - | 1.37% |
Buyback Yield / Dilution | 7.07% | 1.15% | -1.35% | -3.35% | 5.07% | -14.68% |